2BB score and signals
Ernexa Therapeutics Inc.’s current 2BB score is 26 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 8 | Very Weak |
| Quality | 20 | Weak |
| Risk | 17 | Very Low |
2BBBullish & Bearish
Ernexa Therapeutics Inc. (ERNA) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 26 out of 100.
Ernexa Therapeutics Inc.’s current 2BB score is 26 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 8 | Very Weak |
| Quality | 20 | Weak |
| Risk | 17 | Very Low |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -3.9168 | — | — |
| 2026-08-11 | — | -3.366 | — | — |
| 2026-05-05 | — | — | — | — |
| 2026-03-10 | — | — | — | — |